AstraZeneca PLC is 49.9x more valuable than Mirum Pharmaceuticals, Inc. by market capitalization ($286.27 B vs $5.73 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MIRM | AZN |
|---|---|---|
| Market cap | $5.73 B | $286.27 B |
| US-listed rank | #1294 | #45 |
| Revenue (latest FY) | $521.31M | - |
| Net income (latest FY) | -$23.36M | - |
| Net margin | -4.5% | - |
| SEC filings | 612 | 1,004 |
AstraZeneca PLC is 49.9x more valuable than Mirum Pharmaceuticals, Inc. by market capitalization ($286.27 B vs $5.73 B).
Full pages: Mirum Pharmaceuticals, Inc. and AstraZeneca PLC, or browse the full rankings.